FIELD: medicine.
SUBSTANCE: group of inventions relates to a haemostat composition, which is able to safely, gradually and completely decompose in a human or animal body in about 30 days and, as a result, can be used by medical professionals to stop bleeding and promote healing both after and during surgery.
EFFECT: degradable haemostat composition is disclosed.
29 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
DEGRADABLE HAEMOSTAT COMPOSITION | 2014 |
|
RU2682336C2 |
COMPOSITION FOR TEMPORARY CONTROL OF BLEEDING | 2023 |
|
RU2819603C1 |
LOCAL HEMOSTATIC AGENT | 2023 |
|
RU2807892C1 |
HAEMOSTATIC MATERIAL | 2012 |
|
RU2824974C2 |
COMPOSITION FOR WOUND BANDAGES | 2016 |
|
RU2775940C2 |
GELATIN-TRANSGLUTAMINASE HEMOSTATIC BANDAGES AND ISOLATING AGENTS | 2007 |
|
RU2464015C2 |
HEMOSTATIC COMPOSITION COMPRISING HYALURONIC ACID | 2005 |
|
RU2369408C2 |
HAEMOSTATIC COMPOSITION CONTAINING HYALURONIC ACID | 2009 |
|
RU2486921C2 |
METHOD FOR PRODUCING CHITOSAN WITH LOW ENDOTOXIN CONTENT | 2014 |
|
RU2751231C2 |
METHOD OF PRODUCING CHITOSAN WITH LOW ENDOTOXIN CONTENT | 2014 |
|
RU2747702C2 |
Authors
Dates
2019-03-21—Published
2014-05-28—Filed